Skip to main content
Premium Trial:

Request an Annual Quote

Centogene to Provide Diagnostic Testing Services for PTC Therapeutics Gene Therapy Program

NEW YORK — Centogene said on Monday that it has signed an agreement to provide diagnostic testing services for aromatic L-amino acid decarboxylase (AADC) deficiency to PTC Therapeutics, which is developing a treatment for the rare disease.

The disease is caused by mutations in the dopa decarboxylase (DDC) gene, resulting in the body's failure to synthesize the AADC enzyme, which is required for the production of the neurotransmitters dopamine and serotonin. While there is no approved treatment for AADC deficiency, PTC is developing a gene therapy for the disease.

Under the deal with PTC, Rostock, Germany-based Centogene said that it will use its CentoCard dried blood spot collection kit to collect patient samples, which it will analyze for the AADC deficiency biomarker 3-O-methyldopa (3OMD) via mass spectrometry. In cases where samples test positive for abnormal 3OMD levels, next-generation sequencing of DDC and variant analysis will be conducted. Deletion/duplication analysis will be run if no mutation is identified via NGS. 

Additional terms were not disclosed.

Centogene noted that it is also in the process of validating DDC enzyme activity from dried blood spots in order to offer 3OMD, NGS and DDC enzyme activity testing using a single CentoCard. 

"We aim to provide physicians with a consensus diagnosis that includes a biomarker and genetic validation from a single source," Centogene CEO Arndt Rolfs said in a statement.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.